Data from Congress.gov, YouTube, and other public sources.

Search Privacy Terms Contact

H.R. 4404 — Depression Side Effect Labeling Awareness Act of 2019 | PoliFocus

H.R. 4404116th Congress

Depression Side Effect Labeling Awareness Act of 2019

To amend the Federal Food, Drug, and Cosmetic Act to require that the label of drugs with an increased risk of suicide or depression present such increased risk prominently, and for other purposes.

Sponsors

Rep. Rush, Bobby L. [D-IL-1]

7 cosponsors

Subjects

Health

Summary

Depression Side Effect Labeling Awareness Act of 2019

This bill specifies that, if a drug's label indicates an increased risk of suicide or depression, this information must displayed prominently.

Full Text

Legislative Actions

2019-09-19
Introduced in House
2019-09-19
Introduced in House
2019-09-19
Referred to the House Committee on Energy and Commerce.
2019-09-20
Referred to the Subcommittee on Health.

Ask about this bill

checking server…

Ask anything about this bill. The AI reads the full text to answer.

Enter to send · Shift+Enter for new line